SN
Sirius NeoSight is a biotech company developing methods to detect subclinical neo-cancers and provide early treatment. Their focus is on identifying nascent cancerous cells before they become symptomatic, enabling proactive therapeutic intervention.
Updated 3 months ago
Funding
$4.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Sirius NeoSight is a biotech company developing methods to detect subclinical neo-cancers and provide early treatment. Their focus is on identifying nascent cancerous cells before they become symptomatic, enabling proactive therapeutic intervention.